Omeros Corporation (OMER) is a publicly traded Healthcare sector company. As of November 10, 2026, OMER trades at $17.35 with a market cap of $1.27B and a P/E ratio of 9.94. OMER moved -1.54% today. Year to date, OMER is +5.53%; over the trailing twelve months it is +161.91%. Its 52-week range spans $2.95 to $21.24. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces OMER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks OMER insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $17.35 |
| Market Cap | $1.27B |
| P/E Ratio | 9.94 |
| EPS | $1.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.24 |
| 52-Week Low | $2.95 |
| Volume | 522.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $38.42M |
| Net Income | $124.83M |
| Gross Margin | 0.00% |
3 analysts cover OMER: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.